Early research (Phase 1)Ended earlyNCT03936959What this trial is testingLY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced CancerWho this might be right forAdvanced Cancer Eli Lilly and Company 10
Testing effectiveness (Phase 2)UnknownNCT04367025What this trial is testingEfficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric CancerWho this might be right forGastric Cancer Chinese PLA General Hospital 70
Testing effectiveness (Phase 2)UnknownNCT05138146What this trial is testingClinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue SarcomaWho this might be right forSarcoma, Soft Tissue Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 70
Early research (Phase 1)Study completedNCT04047862What this trial is testingStudy of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid TumorsWho this might be right forLocally Advanced and Metastatic Solid Tumors BeiGene 446
Testing effectiveness (Phase 2)Study completedNCT02061761What this trial is testingEvaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell MalignanciesWho this might be right forHematologic Neoplasms Bristol-Myers Squibb 106
Early research (Phase 1)Study completedNCT00703469What this trial is testingMDX-1106 to Treat Patients With Hepatitis C InfectionWho this might be right forHepatitis C Bristol-Myers Squibb 54
Testing effectiveness (Phase 2)Study completedNCT03623854What this trial is testingNivolumab and Relatlimab in Treating Participants With Advanced ChordomaWho this might be right forChordomaLocally Advanced ChordomaMetastatic Chordoma+1 more Jonsson Comprehensive Cancer Center 10
Large-scale testing (Phase 3)Looking for participantsNCT06857175What this trial is testingA Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Urothelial Carcinoma(PANKU-Bladder01)Who this might be right forUrothelial Carcinoma Sichuan Baili Pharmaceutical Co., Ltd. 508
Testing effectiveness (Phase 2)Study completedNCT04732494What this trial is testingAnti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma BeiGene 125
Testing effectiveness (Phase 2)UnknownNCT04303741What this trial is testingA Phase II Trial of Camrelizumab in Combination With Apatinib and Eribulin in Patients With Advanced TNBCWho this might be right forBreast Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 46
Testing effectiveness (Phase 2)UnknownNCT05311566What this trial is testingPD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical CancerWho this might be right forCervical CarcinomaChemoradiotherapyAnti-programmed Cell Death Receptor 1+6 more Lei Li 92
Testing effectiveness (Phase 2)UnknownNCT04026841What this trial is testingThe Efficacy of PD-1 Antibody Sintilimab on Early-stage Multiple Primary Lung Cancer With Ground Glass Density.Who this might be right forMultiple Primary Lung Cancers The First Affiliated Hospital of Guangzhou Medical University 36
Testing effectiveness (Phase 2)Looking for participantsNCT06393361What this trial is testingChidamide Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant.Who this might be right forIneligible Or Refused Transplant Patients With Classical Hodgkin Lymphoma Chinese PLA General Hospital 100
Early research (Phase 1)Ended earlyNCT05904496What this trial is testingBGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid Tumors BeiGene 44
Early research (Phase 1)Study completedNCT03287427What this trial is testingMYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies TrialWho this might be right forColorectal CancerAdenoid Cystic Carcinoma Peter MacCallum Cancer Centre, Australia 27
Not applicableStudy completedNCT06818097What this trial is testingEfficacy of Target - Immunotherapy and XELOX Chemotherapy for Advanced HCCWho this might be right forAdvanced HCCSystemic TherapyChemotherapy+3 more Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 68
Large-scale testing (Phase 3)Active Not RecruitingNCT05374512What this trial is testingDato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)Who this might be right forBreast Cancer AstraZeneca 644
Large-scale testing (Phase 3)UnknownNCT03707509What this trial is testingPhase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Jiangsu HengRui Medicine Co., Ltd. 263
Not applicableUnknownNCT06281912What this trial is testingImpact of Anti PD-1 Therapy in Children, Adolescents and Young Adults (CAYA) Melanoma PatientsWho this might be right forEarly MelanomaAdvanced Melanoma Azienda Ospedaliera di Perugia 70
Testing effectiveness (Phase 2)UnknownNCT05723432What this trial is testingKD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced MelanomaWho this might be right forMelanoma Shanghai Kanda Biotechnology Co., Ltd. 84